The World Stroke Organization is the only global body solely focused on stroke. With around 3500 individual and 100society members spanning every global region, we represent over 55,000 stroke specialists in clinical, research and community settings.
Viz.AI
Viz.ai is the leading platform, leveraging artificial intelligence and machine learning to improve clinical care and accelerate treatments and technology. The Viz Platform is a transformative solution that uses artificial intelligence to unify synchronized care collaboration, high fidelity mobile image viewing, real-time patient information and secure communication to optimize workflows for better patient care coordination. Viz.ai’s comprehensive vascular portfolio includes care coordination products for detection of suspected pulmonary embolism with automated RV/LV ratio and aortic disease. These solutions leverage advanced deep learning to communicate time-sensitive information about patients straight to a specialist who can intervene and treat. Viz is the most comprehensive and effective AI platform that is already helping to coordinate care across a broad list of clinical applications in more than 1,800 hospitals. | Viz.ai is the leading platform, leveraging artificial intelligence and machine learning to improve clinical care and accelerate treatments and technology. The Viz Platform is a transformative solution that uses AI to unify care collaboration. | Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,800+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One® is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit Viz.ai.
TAHO Pharmaceuticals
AHO is a commercial-stage specialty pharma pioneering in oral, transdermal drug delivery systems. Collaborating with our partners across three continents, our pipeline of medicines targets CNS, Geriatric, and Pediatric therapies that provide caregivers with significant treatment options. From concept to commercial, we have several products launched in major markets. Trusted by partner pharma, we devote toward partner value and innovation. | TAHO Pharmaceuticals, founded in 2010 in Taipei, Taiwan, and listed on the Taipei Exchange, is dedicated to transforming drug delivery with heart and innovation. We specialize in advanced formulations that make oral and injectable medications safer, more effective, and easier to use. Our mission is to enhance patient lives with thoughtful, next-generation solutions for diverse needs, especially those struggling with traditional treatments. Our success stems from our proprietary Transepithelial Delivery System (TDS) platform. It features: Transdermal Delivery: Patches provide steady medication through the skin, eliminating injections or frequent dosing—ideal for chronic care. Transmucosal Delivery: Oral thin films ensure rapid onset, enhanced bioavailability, and improved experience via the mucosa. We’re not merely creating new delivery methods—we are redefining the future of healthcare with compassion, ensuring our innovations bring hope and comfort to patients and caregivers. | TAHO Pharmaceuticals Ltd., founded in 2010 and headquartered in Taipei, Taiwan, is a publicly listed company on the Taipei Exchange. The company focuses on advancing drug delivery through innovative formulation technologies that improve the safety, efficacy, and convenience of existing medications. Leveraging its proprietary Transepithelial Delivery System (TDS) platform, TAHO develops transdermal and transmucosal drug delivery solutions designed to enable efficient drug absorption, improve patient compliance, and optimize therapeutic outcomes. By creating patient-friendly alternatives to traditional oral and injectable medications, TAHO is committed to addressing unmet medical needs and improving quality of life for patients worldwide. | TAHO is an R&D-driven specialty pharma pioneering oral and transdermal drug-delivery systems. TAHO’s Transepithelial Delivery System enables the development of oral dissolving films and transdermal patches for anticoagulants and many other treatments
Phagenesis
Phagenesis is a leading medical technology company pioneering neuromodulation therapy for neurogenic dysphagia, a swallowing disorder commonly seen after stroke or other neurological injury. The company’s Phagenyx® Neuromodulation System delivers pharyngeal electrical stimulation (PES) to retrain neural pathways and restore swallowing control. Supported by more than 30 clinical publications and real-world evidence, Phagenyx has demonstrated faster return to oral nutrition, reduced aspiration risk and shorter hospital stays. In the United States, Phagenyx is indicated for treating severe dysphagia post-stroke, while outside the U.S., it is CE-marked for use in a broad range of neurological causes.
Patronus Neurology, LLC
Patronus provides elite 24 x 7 comprehensive emergency teleneurology solutions to hospitals and stroke centers for any neurological question or emergency. Our response times put patients in contact with vascular neurologists in under two minutes.
NEAR Brain
We develop non-invasive software that accurately predicts cerebral blood flow from medical imaging, enabling neurosurgeons and neurologists to anticipate complications, improve prognosis prediction, and optimize treatment planning.
Medtronic
Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. | We lead global healthcare technology. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people. Transforming the lives of two people every second, every hour, every day. Medtronic. | We lead global healthcare technology, boldly attacking the most challenging problems. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people, and our technologies transform the lives of two people every second, every hour, every day. Expect more from us. Medtronic. Engineering the extraordinary. | We lead global healthcare technology. Our Mission: to alleviate pain, restore health, & extend life, unites a global team of people. Transforming the lives of two people every second, every hour, every day. Medtronic. Engineering the extraordinary. | edtronic is a global leader in medical technology dedicated to improving healthcare and transforming patient outcomes through innovation and collaboration. Through its technologies, the Coronary and Renal Denervation operating unit seeks to improve health for the one billion people living with high blood pressure globally, and the 315 million people living with coronary artery disease around the world. | Bold thinking. Bolder actions. We are Medtronic. We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission – to alleviate pain, restore health, and extend life – unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second.
Genomadix Inc
The Genomadix Cube CYP2C19 System delivers accurate genotyping results in 1 hour, enabling personalized dual-antiplatelet therapy. It’s suitable for any healthcare setting, facilitating timely genotype-guided DAPT for optimized patient care.
Bayer
Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. The oncology franchise includes both marketed products and clinical development compounds, which reflect the company’s approach to research: prioritizing targets and pathways with the potential to impact the way that cancer is treated. | Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare. Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world. See Bayer’s Privacy Statement at https://www.bayer.com/en/privacy-statement. | Bayer is a global life sciences leader in healthcare & nutrition. Building on a 150-yr legacy in healthcare, Bayer is committed to improving patient lives by developing therapies & delivering 1st-in-class educational & support programs to meet needs. | Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing aging population. Bayer is committed to the principles of sustaining development, and the Bayer brand stands for trust, reliability, and quality throughout the world. Bayer Medical Information: https://askmed.bayer.comPrivacy Statement: https://labeling.bayerhealthcare.com/html/privacy.htm | Building on a century of expertise, Bayer Radiology is committed to advancing radiology, guided daily by our purpose—everyone deserves clear answers about their health. With a passionate team and a presence in more than 140 countries, Bayer is a global leader in medical imaging. Our mission is to shape the patient experience, beginning with diagnostic care, to help improve patient outcomes. Bayer Radiology’s leading radiology portfolio features contrast agents and devices for precise administration across modalities including computed tomography (CT), X-ray and magnetic resonance (MR), and positron emission tomography (PET). The portfolio is complemented by an end-to-end diagnostic support ecosystem that includes power injection systems with sterile disposables, 24/7 equipment service, enterprise informatics, and clinical support. Fully committed to the ongoing advancement of medical imaging, Bayer Radiology continues to pioneer solutions that will help health care teams answer critical questions about the diagnosis and monitoring of serious diseases—because everyone deserves clear answers about their health.